Time in Range: why HbA1c is no longer enough
HbA1c has anchored diabetes care for decades. It is an average — and averages hide exactly the information that matters most.
Read articleDiabetes
Glucose mastery, not just control.
Diabetes is manageable and often reversible. Continuous glucose monitoring plus metabolic medicine gets patients to lasting stability rather than a managed decline.
CGM-guided diabetes care built around your glucose data, not population averages.
Our approach
Your pathway
From first appointment to ongoing review.
Full history and medication review
CGM fitting, then a two-week data readout
Monthly HbA1c tracking and target adjustment
Priority access during glucose crises
Questions
In many early-to-moderate cases, yes. Intensive lifestyle medicine and weight normalisation can produce significant improvement or full remission.
LADA — latent autoimmune diabetes in adults — is frequently misdiagnosed as Type 2. We test for it specifically and adjust treatment to preserve beta-cell function.
A 60-minute first consultation, and a plan built on your own data.